Navigation Links
Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
Date:11/7/2012

suring results from the Light Study may sufficiently characterize the cardiovascular risk of Empatic, so long as the weight loss and blood pressure and heart rate data for Empatic are similar to or more favorable than those of Contrave.  Orexigen owns worldwide rights to Empatic.

Conference Call Today at 5 p.m. Eastern Time (2:00 p.m. Pacific Time)
The Orexigen management team will host a teleconference and webcast to discuss the third quarter 2012 financial results and recent business highlights. The live call may be accessed by phone by calling 888-895-5479 (US) or 847-619-6250 (International), participant code 33664518. The webcast can be accessed live on the investor relations section of the Orexigen web site at http://www.orexigen.com, and will be archived for 14 days following the call.

About Orexigen Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.

Forward-Looking Statements
Orexigen cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "indicates," "will," "should," "intends," "potential," "suggests," "assuming," "designed" and similar expressions are intended to identify forward-looking statements. These statements are based on the Company's current beliefs
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
10. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
11. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... CENTER, Ohio , May 22, 2013 /PRNewswire/ ... Opioid Defense Manager™ (ODM).  Launched in November 2012 ... revolutionary managed care program to stop the rising ... is a proactive, customized program designed to protect ... use while maintaining the necessary balance to provide ...
(Date:5/22/2013)... N.C. , May 22, 2013 STEPh, ... to announce the launch of their web site ( ... [STEPh Reports].  About STEPh Reports ... in development.  Each STEPh Report assesses ... trials data, projected launch year, company, and specific key ...
(Date:5/22/2013)... , May 22, 2013 MEDIFIRST SOLUTIONS, ... to update shareholders about some recent company developments. As ... its avenues of communication with shareholders. Integrating social media ... a Facebook page and will post updates on Twitter.  ... hashtag is #medifirstusa. Says CEO ...
Breaking Medicine Technology:Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Medifirst Solutions, Inc. Announces Update To Shareholders 2
... The award recognizes outstanding journalism demonstrating the ... discoveries and scientific,breakthroughs., WASHINGTON, June 19 ... announces the winners of the 7th Annual,Michael ... in honor of FBR,s,Chairman and 2008 Congressional ...
... Kendle (Nasdaq: KNDL ), a,leading global full-service ... its experts will present at the upcoming Drug,Information ... scheduled,for June 22-26, 2008, at the Boston Convention ... speak on key topics in the clinical,development industry, ...
Cached Medicine Technology:The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards 2Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 2Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 3
(Date:5/23/2013)... May 23, 2013 Following the recent ... UK internet users, the security team at idcloak Technologies ... safeguards against this or any web-born malware. Gill-Chris ... technology provides far better privacy and security ... underlined that even the best AV software cannot be ...
(Date:5/23/2013)... Shirataki noodles are growing in popularity since ... strategy. These noodles are originally from Japan and are ... weight, diet and exercise are the two major key ... only research shirataki noodles but offers tons of delicious ... Shirataki noodles are very healthy and contain ...
(Date:5/23/2013)... May 23, 2013 AttorneyOne.com, a recognized ... are now actively providing expert opinion in view of ... lawsuits. , According to court documents, on March 5, ... District Court (case no. 3:2013cv50102) alleging that her husband ... Boehringer Ingelheim Pharmaceuticals, is mainly used as a blood ...
(Date:5/23/2013)... May 23, 2013 Daimer Industries, ... high-grade auto detailing systems , including outstanding car ... , as well as other popular cleaning machines ... nations worldwide, is now offering the Super Max™ ... help manage a myriad of cleaning applications, such ...
(Date:5/22/2013)... The surging growth in specialty beds ... marketing claims to compare mattresses often proves a bit ... bed blog , offers shoppers faced with this dilemma ... latest article. , Titled “ Mattress Comparison Overview – ... readers through the basics of innerspring beds as well ...
Breaking Medicine News(10 mins):Health News:Effective virus protection without anti-virus software, identifies idcloak 2Health News:DietNoodleShop.com is Re-launching; Adding More Diet Recipes Along with Information on Shirataki Noodles 2Health News:New Lawsuit on Pradaxa Brain Hemorrhage: Now, AttorneyOne Can Provide Advice 2Health News:Commercial Pressure Washer Debuted By Daimer Industries For Wheelchair Cleaning 2Health News:Commercial Pressure Washer Debuted By Daimer Industries For Wheelchair Cleaning 3Health News:Commercial Pressure Washer Debuted By Daimer Industries For Wheelchair Cleaning 4Health News:Mattress Comparison Overview Released by The Sleepy Shopper; Compares Top Types and Brands 2
... WEDNESDAY, Feb. 16 (HealthDay News) -- The way women ... eating disorder, researchers suggest. They found that women ... than women without eating disorders. The study, by ... and 40 women with no eating disorder, half of ...
... Interview Survey (CHIS), the nation,s largest state health survey ... population, released its latest data today on more than ... state,s residents. The randomdigit-dial telephone ... for Health Policy Research, gathers essential information from tens ...
... WEDNESDAY, Feb. 16 (HealthDay News) -- A genetic mutation ... against cancer and diabetes, a new study finds. ... drugs or other methods to achieve similar protection in ... of Southern California cell biologist, and Ecuadorian endocrinologist Jaime ...
... When doctors discover high concentrations of regulatory T cells in ... grim, though why exactly has long been unclear. ... School of Medicine suggests these regulatory T cells, whose job ... protein that appears to hasten and intensify the spread of ...
... five homeless people with tuberculosis die within a year of ... Hospital,s Dr. Kamran Khan. And that number remains unchanged over ... prevention and control of tuberculosis in homeless shelters. A ... homeless man who died of tuberculosis in Toronto in 2001, ...
... dropping out are particularly sensitive to a handful of critical ... a study led by Michigan State University scholars. Surprisingly, ... and students, failure to get their intended major did not ... said Tim Pleskac, MSU assistant professor of psychology and lead ...
Cached Medicine News:Health News:Self-Drawings May Reveal Hidden Eating Disorders 2Health News:California Health Interview Survey releases newest data on state residents' health 2Health News:Dwarfism Mutation May Protect From Cancer, Diabetes 2Health News:Key culprit identified in breast cancer metastasis 2Health News:Death rate from tuberculosis in homeless alarmingly high: Study 2Health News:MSU-led study identifies risks for quitting college 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: